Home / News / India News / Article /
Dr Reddy's launches Avigan tablets in India for COVID-19
Updated On: 19 August, 2020 09:18 PM IST | | IANS
Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate COVID-19 disease
Listen to this article :
Thsi picture has been sued for representational purpose only
Pharma major Dr Reddy's Laboratories Ltd on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets for treatment of Covid-19 in India.
The launch is part of the global licensing agreement with Fujifilm Toyama Chemical Co. Ltd that grants Dr Reddy's the exclusive rights to manufacture, sell and distribute Avigan (Favipiravir) 200 mg tablets in India.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT